At A Glance
1
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy.
2
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Fundamentals
How The Business Makes Money
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.
Industry Medical - Diagnostics & Research
Activity
What Changed Recently
No significant events in the past 90 days.
Company Profile
CIKUNKNOWN_IBXXF
ISINAU000000IBX6
Phone855 564 5264
Address5601 Oberlin Drive, San Diego, CA, 92121, US
SEC EDGAR